Literature DB >> 9710032

Phenotypic variation in leukoencephalopathy with vanishing white matter.

M S van der Knaap1, W Kamphorst, P G Barth, C L Kraaijeveld, E Gut, J Valk.   

Abstract

OBJECTIVE: The objective of this study is to describe milder and later onset variants of a recently described leukoencephalopathy with vanishing white matter.
BACKGROUND: The diagnostic criteria used currently for this disease include an early-childhood onset of neurologic deterioration.
METHODS: Clinical, MRI, and spectroscopic findings of five patients were reviewed who fulfilled all inclusion criteria for the disease of vanishing white matter, apart from the age at onset. In one patient histopathologic findings were documented.
RESULTS: Onset of the disease was in late childhood or adolescence in four patients, and one patient was still presymptomatic in his early twenties. The course of the disease tended to be milder than in the patients with early-childhood onset. MRI revealed a diffuse cerebral hemispheric leukoencephalopathy with evidence of white matter rarefaction. MRS of the abnormal white matter showed a serious decrease but not complete disappearance of all "normal" signals and, in some patients, the presence of extra signals from lactate and glucose. Changes in relative spectral peak heights were compatible with axonal damage or loss, but not with active demyelination or substantial gliosis. Autopsy in one patient confirmed the extensive rarefaction of the cerebral white matter. There was a commensurate loss of axons and myelin sheaths. Within the brainstem, pontine lesions were present, also involving the central tegmental tracts--a phenomenon previously described in early-onset patients.
CONCLUSION: Later onset does occur in the disease of vanishing white matter, and both MRS and histopathology are compatible with a primary axonopathy rather than primary demyelination.

Entities:  

Mesh:

Year:  1998        PMID: 9710032     DOI: 10.1212/wnl.51.2.540

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  1H chemical shift imaging, MRI, and diffusion-weighted imaging in vanishing white matter disease.

Authors:  Paul E Sijens; Maartje Boon; Linda C Meiners; Oebele F Brouwer; Matthijs Oudkerk
Journal:  Eur Radiol       Date:  2005-04-27       Impact factor: 5.315

2.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

3.  Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.

Authors:  Roberta La Piana; Adeline Vanderver; Marjo van der Knaap; Louise Roux; Donatella Tampieri; Bernard Brais; Geneviève Bernard
Journal:  Arch Neurol       Date:  2012-06

4.  A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy.

Authors:  Isla Ogilvie; Nancy G Kennaway; Eric A Shoubridge
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 5.  Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies.

Authors:  Xavier Ayrignac; Clemence Boutiere; Clarisse Carra-Dalliere; Pierre Labauge
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

6.  Demonstration of glycine peaks at 3.50 ppm in a patient with van der Knaap syndrome.

Authors:  R N Sener
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

7.  Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders.

Authors:  J Patrick van der Voorn; Petra J W Pouwels; Wout Kamphorst; James M Powers; Martin Lammens; Frederik Barkhof; Marjo S van der Knaap
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

8.  Astrocytes are central in the pathomechanisms of vanishing white matter.

Authors:  Stephanie Dooves; Marianna Bugiani; Nienke L Postma; Emiel Polder; Niels Land; Stephen T Horan; Anne-Lieke F van Deijk; Aleid van de Kreeke; Gerbren Jacobs; Caroline Vuong; Jan Klooster; Maarten Kamermans; Joke Wortel; Maarten Loos; Lisanne E Wisse; Gert C Scheper; Truus E M Abbink; Vivi M Heine; Marjo S van der Knaap
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

9.  eIF2B-related disorders: antenatal onset and involvement of multiple organs.

Authors:  Marjo S van der Knaap; Carola G M van Berkel; Jochen Herms; Rudy van Coster; Martina Baethmann; Sakkubai Naidu; Eugen Boltshauser; Michèl A A P Willemsen; Barbara Plecko; Georg F Hoffmann; Christopher G Proud; Gert C Scheper; Jan C Pronk
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

10.  Diagnostic criteria for pediatric multiple sclerosis.

Authors:  Jennifer P Rubin; Nancy L Kuntz
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.